3,575 research outputs found
Preparation and application of proteomic antibody bank against whole water-soluble proteins from rapid-growing bamboo shoots
No full textResearch on the Strategic Marketing Analysis for the Biotech-Beauty Industry: A Case of Company YJ
No full textAt present, the medical aesthetics industry is growing rapidly and increasingly competitive in the market. With Taiwan's medical aesthetics output value exceeding 40 billion, the consumer base ranges from teens to 60s. This research is based on the marketing strategy research of YJ. Biotechnology Company. YJ. Company is a biotech company that has transformed from OEM to self-owned brand. The founder has a very experienced background in the biotechnology industry and factory has been established for many years. Hoping through this research, the self-created brand can be successfully promoted. In addition to providing high-quality products, YJ. Company has been paid more efforts to consumers' perception of product effects and service.
The research methodology is used case studies, five forces analysis, 4P and SWOT analysis as the research framework. The conclusions and recommendations are that YJ. Company is keeping strengthening advertising and sales channels, meanwhile continuing the company\ue2s insistence on product technology and increasing products with multiple types of services, to establish a strong professional management team. It\ue2s firmly believed that once the business model of experiential marketing is strengthened, it can be forwarded to other Southeast Asian countries, even marketing Taiwan\ue2s products to all over the world. YJ. Company strongly believes to establish the own brand internationally, then marketing into the world
The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-alpha and ribavirin combined therapy for chronic hepatitis C patients.
No full textAssessment of diaphragm and external intercostals fatigue from surface emg using cervical magnetic stimulation
No full text
The synergistic experimental design of the YJ.
No full text<p>The synergistic experimental design of the YJ.</p
Photo-reduction and adsorption in aqueous Cr(VI) solution by titanium dioxide, carbon nanotubes and their composite
No full text[[abstract]]BACKGROUND: This study compared the removal of aqueous Cr(VI) by multi-walled carbon nanotubes (CNTs) modified by sulfuric acid, titanium dioxide (TiO(2)) and composite of CNTs and TiO(2). RESULTS: More than 360 h contact time was needed to completely adsorb 3 mg L(-1) of Cr(VI) by CNTs, indicating that the rate of adsorption by CNTs alone was slow. The reaction time approaching equilibrium depended on the Cr(VI) concentration. XPS analysis of CNTs after adsorbing Cr(VI) showed that the Cr(VI) on the surface of CNTs was partially reduced to Cr(III). A 3 mg L(-1) solution of Cr(VI) was fully photocatalyzed by commercial TiO(2) (Degussa P25) in less than 0.5 h under UV irradiation. Unlike P25, reduction by another commercial TiO(2) (Hombikat UV100) took 4 h and more than 2 h were necessary for reduction by the composite. Thus the efficiency of Cr(VI) photo-reduction by the composite was lower than by TiO(2), but higher than that by CNTs. XPS analysis of TiO(2) and composite showed the existence of both Cr(VI) and Cr(III) on their surfaces. CONCLUSION: In contrast to TiO(2), the reduction rate of aqueous Cr(VI) using CNTs as adsorbent was slow. P25 had a markedly higher photocatalytic efficiency than the composite or UV100 alone. Using P25 to reduce aqueous Cr(VI) has a higher potential for practical application. The diameters of TiO(2) and CNTs and the ratio of TiO(2)/CNTs are key problems in the preparation of TiO(2)/CNTs composite. (C) 2011 Society of Chemical Industry[[note]]SC
The therapeutic effects of YJ with the optimal proportion.
No full text<p>(A)–(C) Effects of YJ on neurological deficits, cerebral infarct volume and content of cerebral water in rats induced by MCAO. EGb761 and YJ were both administered i.g. 15 min prior to MCAO and 6 h after MCAO. (D-1) Detection of cerebral blood flow. The cerebral blood flow perfusion color image [D-1. a (1–5) and c (1–5)], detected position image [D-1. b (1–5)], and blood flow time window [D-1. d (1–5)] are presented. [1, Vehicle control; 2, EGb761-treated group; 3–5, YJ-(1,5 and 25 mg·kg<sup>−1</sup>) treated group]. (D-2) The reduced rate of rCBF. EGb761 and YJ were both administered i.g. 15 min prior to MCAO. Values were expressed as the mean ± SD (A, B and C, n = 10; D, n = 5), and the data were analyzed by one-way ANOVA. <sup>##</sup><i>P</i><0.01,<sup>#</sup><i>P</i><0.05 versus the sham group; <sup>**</sup><i>P</i><0.01,<sup>*</sup><i>P</i><0.05 versus the vehicle control.</p
- …
